Stabilised aqueous preparation based on chloromethyl-/ methylisothiazolone (CMI/ MI)and reaction product of ethylene glycol, urea and paraform

Water based combination of chloromethyl-/ methylisothiazolone (CMI/ MI) and bronopol

Aqueous formulation of Bronopol and chloromethyl-/ methylisothiazolone (3:1)

Solvent based mixture

Ready-to-use formulation of 4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT).

Formulation of 4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)

Aqueous formulation of 1,2-benzisothiazolin-3(2H)-one (BIT)

Glycolic ready-to-use formulation of 2-octyl-2H-isothiazolin-3-one (OIT) and 3-Iodo-2 propynylbutylcarbamate (IPBC)

Aqueous formulation of 1,2-benzisothiazolin-3(2H)-one (BIT), 2-Methyl-2H-isothiazol-3-one (MIT) and Bis(3- aminopropyl)dodecylamin (BDA)

Aqueous formulation of 1,2-benzisothiazolin-3(2H)-one (BIT)

Aqueous alkaline solution of 1,2-benzisothiazolin- 3(2H)-one with 2-methyl-2H-isothiazol-3-one

Bivalent stabilised formulation of mixture of 5-chloro-2-methyl-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (CMIT/MIT)

Formulation of mixture of 5-chloro-2-methyl-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (CMIT/MIT) with Bronopol.